| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 50111-397-01 | 50111-397 | HUMAN PRESCRIPTION DRUG | Hydralazine Hydrochloride | Hydralazine Hydrochloride | TABLET | ORAL | 19900930 | N/A | ANDA | ANDA089098 | Teva Pharmaceuticals USA, Inc. | HYDRALAZINE HYDROCHLORIDE | 100 mg/1 | 100 TABLET in 1 BOTTLE (50111-397-01) |
| 43353-124-05 | 43353-124 | HUMAN PRESCRIPTION DRUG | Hydralazine Hydrochloride | Hydralazine Hydrochloride | TABLET | ORAL | 20151202 | N/A | ANDA | ANDA089098 | Aphena Pharma Solutions - Tennessee, LLC | HYDRALAZINE HYDROCHLORIDE | 100 mg/1 | 4200 TABLET in 1 BOTTLE (43353-124-05) |